Author

Verónica Rendo

Uppsala UniversityORCID 0000-0002-2983-4020Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1

Frequent Co-Authors

Amanda RaineiD· 1 shared Anders LundmarkiD· 1 shared Anna Pia EnbladiD· 1 shared Anna SegermaniD· 1 shared Arja H. Harila‐SaariiD· 1 shared Bengt WestermarkiD· 1 shared Claes R. AnderssoniD· 1 shared Erika DalmoiD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Amanda RaineORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BMP4 induces a p21-dependent cell state shift in glioblastoma linking mesenchymal transition to senescence

Mia Niklasson, Erika Dalmo, Anna Segerman, Verónica Rendo, Bengt Westermark

This study shows BMP4 induces p21-dependent senescence in glioblastoma cells, especially in therapy-resistant mesenchymal-like clones, linking mesenchymal transition to senescence.

International Journal of Molecular Sciences · Apr 23, 2025Peer-reviewedCancer Biology

Recurrent breakpoints in the BRD4 locus reduce toxicity associated with gene amplification

Jeremiah A. Wala, Simona Dalin, Sophie Webster, Ofer Shapira, John P. Busanovich, Shahab Sarmashghi, Rameen Beroukhim, Pratiti Bandopadhayay, Verónica Rendo

This study shows that BRD4 gene deletions reduce toxicity from overexpression in ovarian and breast cancers, providing evidence for a novel mechanism in cancer progression.

Cell Genomics · Mar 19, 2025Peer-reviewedCancer Biology

COMPARISON OF HIGH-THROUGHPUT SINGLE-CELL RNA-SEQ METHODS FOR EX VIVO DRUG SCREENING

Henrik Gezelius, Anna Pia Enblad, Anders Lundmark, Martin Åberg, Kristin Blom, Jakob Rudfeldt, Amanda Raine, Arja H. Harila‐Saari, Verónica Rendo, Merja Heinäniemi, Claes R. Andersson, Jessica Nordlund

The paper compares three scRNA-seq methods for ex vivo drug screening in ALL cells, finding consistent transcriptional responses to fludarabine despite method-specific differences.

NAR Genomics and Bioinformatics · Jan 5, 2024Peer-reviewedGenomics